<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, in addition to total GSRS, the mean reduction in subscales of GSRS Pain (stomachache, hunger pain, and nausea) and GSRS Dyspepsia (borborygmus, abdominal distention, eructation, and increased flatus) after the trial was considerably higher in the intervention arm than the control group. Anticholinergic, antispasmodics, and antibiotics medications are used to treat intestinal symptoms of FGIDs such as diarrhea, abdominal cramps, and symptoms associated with gas retention such as bloating, abdominal distension, and pain [
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B50" ref-type="bibr">50</xref>â€“
 <xref rid="B53" ref-type="bibr">53</xref>]. Meanwhile, various studies have shown anticholinergic and antispasmodic effects [
 <xref rid="B9" ref-type="bibr">9</xref>, 
 <xref rid="B10" ref-type="bibr">10</xref>, 
 <xref rid="B12" ref-type="bibr">12</xref>, 
 <xref rid="B54" ref-type="bibr">54</xref>], antibacterial [
 <xref rid="B9" ref-type="bibr">9</xref>, 
 <xref rid="B10" ref-type="bibr">10</xref>, 
 <xref rid="B13" ref-type="bibr">13</xref>], and antianxiety [
 <xref rid="B55" ref-type="bibr">55</xref>, 
 <xref rid="B56" ref-type="bibr">56</xref>] of essential oil and monoterpenes of ZM, TA, and AG. Accordingly, this study's herbs' properties may contribute to the improvement of gas-related and intestinal symptoms in this study.
</p>
